Follow the people · Insider

JG

Jonathan Gillis

Insider · CAO and Interim CFO · MPLT

Jonathan Gillis files insider transactions with the SEC as a cao and interim cfo of MapLight Therapeutics (MPLT). We hold 6 disclosed purchases and sales filed since 23 June 2017, 3 of them in the last 90 days.

  • Files forMPLT
  • Disclosed buys and sells6 in all, 3 in the last 90 days
  • Last disclosure19 August 2026

Positions held

3 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 27 October 202517 August 2026CAO and Interim CFO · MapLight Therapeutics (MPLT)25 Form 4 lines · source: SEC Form 4
  • Filed 10 May 201810 May 2018Senior Vice President, Finance · Millendo Therapeutics (MLND)1 Form 4 line · source: SEC Form 4
  • Filed 21 June 20178 February 2018Senior Vice President, Finance · OvaScience (OVAS)2 Form 4 lines · source: SEC Form 4

Everything they disclosed

28 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.